Refractory Hepatocellular Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 0 | Terminated | 1 |
| DB17109 | Tegavivint | 1 / 2 | Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |